RxDoctor Payments Data

Darrell Bunch, DO

Family Medicine · Longview, TXNPI 1710974811

Payments from drug & device makers

$724in general payments, 2019–2025

Across 44 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$164
  • AbbVie$111
  • Pfizer$92
  • GSK$74
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$61
  • Abbott$52
  • plus $170 from 10 others

What the payments were for

  • Food & beverage$724100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$724 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$146,460
Medicare patients
347
Services billed
2,229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban196$78,497
JanuviaSitagliptin Phosphate77$45,546
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$43,396
FarxigaDapagliflozin Propanediol76$40,407
VraylarCariprazine Hcl25$37,184
RybelsusSemaglutide33$36,148
TrulicityDulaglutide30$33,479
MounjaroTirzepatide15$28,629
OzempicSemaglutide23$24,299
JardianceEmpagliflozin26$20,149
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,763
XareltoRivaroxaban23$13,249
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen410$11,060
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$10,517
BrilintaTicagrelor21$9,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$78,497196 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$164$70,161138 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix, Incruse Ellipta$74$62,789110 claims
Lilly USA, LLCTrulicity, Mounjaro$41$62,10745 claims
AbbVieVraylar, Linzess$111$43,78637 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →